U.S. Banks Post Net Income of $37.6 Billion in the Third Quarter — Highest Amount in Six Years

The Paragon Report Provides Stock Research on BB&T and First Horizon National

Continue Reading

Number of Special Dividend Payments Surge in 2012 as Companies Look to Avoid Dividend Tax Increase

Five Star Equities Provides Stock Research on The Dow Chemical Company and Leggett & Platt

Continue Reading

Special Dividend Payments in 2012 Are Four Times the Amount Seen in 2011

Five Star Equities Provides Stock Research on Abbott Laboratories and Tellabs

Continue Reading

U.S. Banks Post Best Quarter Since the Financial Crisis

The Paragon Report Provides Stock Research on Fifth Third Bancorp and Regions Financial

Continue Reading

Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Celldex Therapeutics and Neostem

Continue Reading

Copper Demand Expected to Exceed Supply in the First Half of 2013

The Paragon Report Provides Stock Research on Sterlite Industries and Thompson Creek Metals

Continue Reading

Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms

Five Star Equities Provides Stock Research on Bristol Myers Squibb and Pfizer

Continue Reading

Amount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011

Five Star Equities Provides Stock Research on Ameren and Pepco Holdings

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Neuralstem and Cyclacel Pharmaceuticals

Continue Reading

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on StemCells and Aastrom Biosciences

Continue Reading